How can I help NAMA-R?Here’s how.
|
How can I help NAMA-R?Here’s how.
|
Education Series Number 1 March 1991 Arlene Ford helped to start one of the first methadone advocacy groups at Nassau County Medical Center. This article was written for the COMPA Newsletter for distribution at the National Methadone Conference. Methadone has allowed me to salvage my life. In May of 1988, following a fourth relapse, my…
National Alliance of Methadone Advocates Inc. FOR IMMEDIATE RELEASE July 25, 1998 435 Second Avenue, New York, NY 10010 Contact: Joycelyn Woods Policy Statement (212) 595-6262 Press Release Mayor Guilianis Announcement About Plan to Close Methadone Programs in New York City Uses a Misunderstood Drug Treatment to Promote Celebrity at the…
STOP METHADONE IGNORANCE It is not uncommon for individuals with a long history of illicit opiate use to remain in methadone treatment as a long term patient. Many often say that without methadone treatment they would probably be dead. Other forms of treatment were not effective and they had come to believe that they would…
Official NAMA Recovery Products NAMA Recovery Logo Bear You knew it had to happen. The Logo Bear is great to set on your desk so everyone knows you support NAMA. It is also good for snuggling on cold nights. Price: $18.99 Click Here to Purchase The NAMA Recovery CD Containing NAMA Recovery Publications: Start a…
Basic Information About DATA On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of schedule III, IV or V opioid treatment drugs that are approved by the FDA for maintenance or detoxification treatment. Summary of Title XXXV NIDA/SAMHSA Announcement & Press Release NIDA Research and…
Mechcatie, Elizabeth. Family Practice News 32(22): 7. November 15, 2002 The approval of the partial opioid agonist buprenorphine for treating opiate dependence has paved the way for office-based treatment of opioid addiction and far greater access to treatment for hundreds of thousands of heroin addicts across the country. Two sublingual formulations have been approved: Buprenorphine…